Robert Bagin

1.5k total citations
25 papers, 1.1k citations indexed

About

Robert Bagin is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Robert Bagin has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Robert Bagin's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Robert Bagin is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Robert Bagin collaborates with scholars based in United States, United Kingdom and Italy. Robert Bagin's co-authors include Bonnie Hepburn, Simon Travis, William J. Sandborn, E. David Ballard, Luigi Moro, Michael Huang, Susan Groshen, Richard Jones, D Alarcón-Segovia and James A. Tumlin and has published in prestigious journals such as Gastroenterology, Cancer and CHEST Journal.

In The Last Decade

Robert Bagin

25 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Bagin 298 284 244 201 188 25 1.1k
Hisashi Shiga 297 1.0× 388 1.4× 306 1.3× 127 0.6× 130 0.7× 90 1.0k
Hooi C. Ee 301 1.0× 385 1.4× 523 2.1× 185 0.9× 397 2.1× 43 1.3k
Seamus Murphy 179 0.6× 236 0.8× 617 2.5× 205 1.0× 93 0.5× 44 1.6k
Winnie Ricker 289 1.0× 68 0.2× 357 1.5× 56 0.3× 282 1.5× 21 1.3k
Dominique Béchade 198 0.7× 88 0.3× 349 1.4× 145 0.7× 235 1.3× 89 927
Meena Thayu 532 1.8× 639 2.3× 307 1.3× 42 0.2× 473 2.5× 59 2.0k
Peter D. Peng 122 0.4× 190 0.7× 587 2.4× 40 0.2× 572 3.0× 39 1.8k
Hervé Hagège 469 1.6× 140 0.5× 400 1.6× 125 0.6× 145 0.8× 75 1.1k
Michael J. Burt 512 1.7× 417 1.5× 419 1.7× 151 0.8× 66 0.4× 28 1.3k
Selvi Thirumurthi 327 1.1× 237 0.8× 333 1.4× 98 0.5× 497 2.6× 44 994

Countries citing papers authored by Robert Bagin

Since Specialization
Citations

This map shows the geographic impact of Robert Bagin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bagin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bagin more than expected).

Fields of papers citing papers by Robert Bagin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bagin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bagin. The network helps show where Robert Bagin may publish in the future.

Co-authorship network of co-authors of Robert Bagin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bagin. A scholar is included among the top collaborators of Robert Bagin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bagin. Robert Bagin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lichtenstein, Gary R., Simon Travis, Silvio Danese, et al.. (2015). Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis. Journal of Crohn s and Colitis. 9(9). 738–746. 28 indexed citations
2.
DuPont, Herbert L., AnnKatrin Petersen, Zhi‐Dong Jiang, et al.. (2014). Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Study. Journal of Travel Medicine. 21(6). 369–376. 18 indexed citations
3.
Lichtenstein, Gary R., William J. Sandborn, Michael Huang, et al.. (2013). Sa1220 Budesonide MMx® 9 mg Induces Remission in Mild-to-Moderately Active UC Patients Regardless of Prior History of 5-ASA Therapy. Gastroenterology. 144(5). S–234. 2 indexed citations
4.
Sandborn, William J., et al.. (2013). P-144 Symptom Resolution and Clinical and Endoscopic Remission Both Resulted in Improved Quality of Life in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 19. S82–S82. 1 indexed citations
5.
Sandborn, William J., Simon Travis, Luigi Moro, et al.. (2012). Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study. Gastroenterology. 143(5). 1218–1226.e2. 181 indexed citations
6.
Travis, Simon, Silvio Danese, L. Moro, et al.. (2012). P162 Induction of clinical and endoscopic remission with budesonide MMX in mild to moderately active ulcerative colitis: Pooled data from two phase 3 studies. Journal of Crohn s and Colitis. 6. S74–S74. 1 indexed citations
7.
Travis, Simon, Silvio Danese, E. David Ballard, et al.. (2012). Su2087 Effect of Long-Term Budesonide MMx 6 mg use on Bone Mineral Density in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study. Gastroenterology. 142(5). S–566. 1 indexed citations
8.
Sandborn, William J., Silvio Danese, E. David Ballard, et al.. (2012). Su2080 Efficacy of Budesonide MMx(r) 6 mg QD for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study. Gastroenterology. 142(5). S–564. 17 indexed citations
9.
Howden, Colin W., et al.. (2009). Control of 24-hour Intragastric Acidity With Morning Dosing of Immediate-release and Delayed-release Proton Pump Inhibitors in Patients With GERD. Journal of Clinical Gastroenterology. 43(4). 323–326. 19 indexed citations
10.
11.
Conrad, Steven A., Andrea Gabrielli, Benjamin D. Margolis, et al.. (2005). Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Critical Care Medicine. 33(4). 760–765. 113 indexed citations
12.
13.
Alarcón-Segovia, D, James A. Tumlin, Richard Furie, et al.. (2003). LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double‐blind, placebo‐controlled study. Arthritis & Rheumatism. 48(2). 442–454. 183 indexed citations
14.
Bierman, Philip J., Robert Bagin, Sundar Jagannath, et al.. (1993). High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients. Annals of Oncology. 4(9). 767–773. 122 indexed citations
15.
Nakamine, Hirokazu, et al.. (1993). Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma. Cancer. 71(10). 3130–3137. 11 indexed citations
16.
Meyers, David G., et al.. (1993). Electrocardiographic Changes in Pericardial Effusion. CHEST Journal. 104(5). 1422–1426. 25 indexed citations
17.
Groshen, Susan, et al.. (1987). Association of Serum Iron, Serum Transferrin Saturation, and Serum Ferritin with Survival in Acute Lymphocytic Leukemia. Journal of Pediatric Hematology/Oncology. 9(4). 350–355. 26 indexed citations
18.
Hürny, Christoph, Eugene Piasetsky, Robert Bagin, & Jimmie C. Holland. (1987). High Social Desirability in Patients Being Treated for Advanced Cblorectal or Bladder Cancer. Journal of Psychosocial Oncology. 5(1). 19–29. 17 indexed citations
19.
20.
Lee, Arthur K., Ronald A. DeLellis, Paul Peter Rosen, et al.. (1985). ABH Blood Group Isoantigen Expression in Breast Carcinomas—An Immunohistochemical Evaluation Using Monoclonal Antibodies. American Journal of Clinical Pathology. 83(3). 308–319. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisashi Shiga Breakdown of academic impact, for papers by Hooi C. Ee Breakdown of academic impact, for papers by Seamus Murphy Breakdown of academic impact, for papers by Winnie Ricker Breakdown of academic impact, for papers by Dominique Béchade Breakdown of academic impact, for papers by Meena Thayu Breakdown of academic impact, for papers by Peter D. Peng Breakdown of academic impact, for papers by Hervé Hagège Breakdown of academic impact, for papers by Michael J. Burt Breakdown of academic impact, for papers by Selvi Thirumurthi
Rankless by CCL
2026